Vitamin C and Folate Status in Hereditary Fructose Intolerance
Overview
Authors
Affiliations
Background: Hereditary fructose intolerance (HFI) is a rare inborn error of fructose metabolism caused by the deficiency of aldolase B. Since treatment consists of a fructose-, sucrose- and sorbitol-restrictive diet for life, patients are at risk of presenting vitamin deficiencies. Although there is no published data on the status of these vitamins in HFI patients, supplementation with vitamin C and folic acid is common. Therefore, the aim of this study was to assess vitamin C and folate status and supplementation practices in a nationwide cohort of HFI patients.
Methods: Vitamin C and folic acid dietary intake, supplementation and circulating levels were assessed in 32 HFI patients and 32 age- and sex-matched healthy controls.
Results: Most of the HFI participants presented vitamin C (96.7%) and folate (90%) dietary intake below the recommended population reference intake. Up to 69% received vitamin C and 50% folic acid supplementation. Among HFI patients, 15.6% presented vitamin C and 3.1% folate deficiency. The amount of vitamin C supplementation and plasma levels correlated positively (R = 0.443; p = 0.011). Interestingly, a higher percentage of non-supplemented HFI patients were vitamin C deficient when compared to supplemented HFI patients (30% vs. 9.1%; p = 0.01) and to healthy controls (30% vs. 3.1%; p < 0.001).
Conclusions: Our results provide evidence for the first time supporting vitamin C supplementation in HFI. There is great heterogeneity in vitamin supplementation practices and, despite follow-up at specialised centres, vitamin C deficiency is common. Further research is warranted to establish optimal doses of vitamin C and the need for folic acid supplementation in HFI.
A Case Study of a Rare Disease (Fructosemia) Diagnosed in a Patient with Abdominal Pain.
Garbowski L, Walasek M, Firszt R, Chilinska-Kopko E, Blazejewska-Gala P, Popielnicki D J Clin Med. 2024; 13(12).
PMID: 38929922 PMC: 11204229. DOI: 10.3390/jcm13123394.
Clinical Practice Guidelines for the Diagnosis and Management of Hereditary Fructose Intolerance.
Ubeda F, Santander S, Luesma M Diseases. 2024; 12(3).
PMID: 38534968 PMC: 10969590. DOI: 10.3390/diseases12030044.
Zuriaga E, Santander S, Lomba L, Izquierdo-Garcia E, Luesma M Healthcare (Basel). 2024; 12(5).
PMID: 38470684 PMC: 10930640. DOI: 10.3390/healthcare12050573.
Tummolo A, Carella R, De Giovanni D, Paterno G, Simonetti S, Tolomeo M Int J Mol Sci. 2023; 24(23).
PMID: 38069347 PMC: 10707160. DOI: 10.3390/ijms242317024.
Correction: Vitamin C and folate status in hereditary fructose intolerance.
Cano A, Alcalde C, Belanger-Quintana A, Canedo-Villarroya E, Ceberio L, Chumillas-Calzada S Eur J Clin Nutr. 2023; 77(11):1102-1103.
PMID: 37673953 PMC: 10630132. DOI: 10.1038/s41430-023-01334-3.